Clinical Trials Directory

Explore 66,650 clinical trials worldwide

Showing 27651-27700 of 66,650 trials

Active filters:Status: Recruiting

Clinical Trials (66,650)

NCT06385184
Social & QoL Behaviors in Parkinson's Disease
N/ARecruiting
500 participants
Started: Mar 8, 2024 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT06229470
Clinical Utility of Neurophysiological Measurements of ECAP-controlled Closed-loop SCS to Guide Treatment of Chronic Pain
NARecruiting
250 participants
Started: Mar 8, 2024 · Completed: Feb 28, 2027
1 condition1 sponsor25 locations
NCT05874206
CRATOS - Evaluation of Cratos™ Branch Stent Graft System in Treatment of Descending Aorta Lesions
NARecruiting
130 participants
Started: Mar 8, 2024 · Completed: Dec 31, 2031
3 conditions2 sponsors1 location
NCT06157463
FAPI in Rectal Cancer TNT
N/ARecruiting
99 participants
Started: Mar 8, 2024 · Completed: Jul 31, 2028
1 condition2 sponsors1 location
NCT06857058
Standardized Procedure for Intracranial Drug-Eluting Stenting in the Treatment of Intracranial Atherosclerotic Stenosis
NARecruiting
300 participants
Started: Mar 8, 2024 · Completed: Jun 8, 2026
1 condition3 sponsors1 location
NCT06368518
Austrian Hypertrophic Cardiomyopathy Registry
N/ARecruiting
1,000 participants
Started: Mar 8, 2024 · Completed: Mar 31, 2044
1 condition1 sponsor14 locations
NCT06330922
Muscle-tendon Pathology and Metabolic Dysregulation in CP
N/ARecruiting
50 participants
Started: Mar 8, 2024 · Completed: Dec 31, 2025
1 condition3 sponsors1 location
NCT05659381
Heated Intraperitoneal Chemotherapy Followed by Niraparib for Ovarian, Primary Peritoneal and Fallopian Tube Cancer
PHASE3Recruiting
230 participants
Started: Mar 8, 2024 · Completed: Aug 1, 2034
6 conditions2 sponsors51 locations
NCT06354530
A Study of Neoadjuvant Therapy for the Treatment of Patients With Locally Advanced Esophageal Squamous Cell Carcinoma
PHASE2/PHASE3Recruiting
266 participants
Started: Mar 8, 2024 · Completed: Dec 31, 2026
2 conditions1 sponsor1 location
NCT06317714
Long-term Follow-up and Quality of Life of Patients Treated With Anticancer Drugs
N/ARecruiting
300 participants
Started: Mar 8, 2024 · Completed: Mar 8, 2027
3 conditions1 sponsor1 location
NCT06105606
Feasibility of the AveCure Microwave Ablation Technology for the Bronchoscopic Treatment of Malignant Central Airway Obstructions
NARecruiting
10 participants
Started: Mar 8, 2024 · Completed: Jan 31, 2027
2 conditions2 sponsors1 location
NCT05265546
Investigating the Mechanisms of the Effects of Psilocybin on Visual Perception and Visual Representations in the Brain
PHASE1Recruiting
80 participants
Started: Mar 8, 2024 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT06223256
A Study of NBL-028 in Patients With Advanced Solid Tumors
PHASE1Recruiting
270 participants
Started: Mar 8, 2024 · Completed: Jan 31, 2027
1 condition1 sponsor1 location
NCT06300918
A Clinical Trial to Evaluate the Time Point of Anti-VEGF Pretreatment of PDR Based on Intraoperative FFA
NARecruiting
60 participants
Started: Mar 8, 2024 · Completed: Aug 1, 2025
1 condition1 sponsor1 location
NCT05785637
Polygraphy at Home for Neuromuscular Patients Under Non-invasive Mechanical Ventilation
N/ARecruiting
25 participants
Started: Mar 8, 2024 · Completed: Mar 31, 2026
1 condition2 sponsors1 location
NCT06273891
Erythromycin Versus Azithromycin for Preterm Prelabor Rupture of Membranes
PHASE3Recruiting
140 participants
Started: Mar 8, 2024 · Completed: Oct 1, 2026
1 condition2 sponsors2 locations
NCT05879432
LSALT Peptide for Prevention or Attenuation of Acute Kidney Injury (AKI) in Patients Undergoing On-Pump Cardiac Surgery
PHASE2Recruiting
240 participants
Started: Mar 8, 2024 · Completed: Nov 30, 2026
2 conditions1 sponsor8 locations
NCT06138275
Elranatamab in R/R Multiple Myeloma
PHASE2Recruiting
32 participants
Started: Mar 8, 2024 · Completed: Dec 1, 2028
3 conditions2 sponsors3 locations
NCT06193512
Efficacy of A Novel RinSe Device to Reduce Oral Bacteria in Intubated IntEnsive CaRe Patients: a Pilot Study
NARecruiting
21 participants
Started: Mar 8, 2024 · Completed: Dec 31, 2025
2 conditions2 sponsors1 location
NCT06055179
XCHT for Irinotecan-Induced Gut Toxicities (Randomized Controlled Trial)
NARecruiting
98 participants
Started: Mar 8, 2024 · Completed: Dec 1, 2026
2 conditions2 sponsors1 location
NCT06182995
Anticipating Decline and Providing Therapy
NARecruiting
120 participants
Started: Mar 8, 2024 · Completed: Nov 30, 2026
5 conditions2 sponsors1 location
NCT05650021
Rectal Spacer for Prostate Cancer Radiation Image Guidance
NARecruiting
30 participants
Started: Mar 8, 2024 · Completed: Sep 1, 2025
1 condition1 sponsor1 location
NCT06310330
TRUST-ACE - Anticancer-treatment Cardiotoxicity Identification by Echocardiography
NARecruiting
250 participants
Started: Mar 8, 2024 · Completed: Dec 31, 2026
1 condition2 sponsors1 location
NCT06318273
A Study to Assess Adverse Events, and How Intravenously (IV) Infused ABBV-969 Moves Through the Bodies of Adult Participants With Metastatic Castration-Resistant Prostate Cancer
PHASE1Recruiting
140 participants
Started: Mar 8, 2024 · Completed: May 31, 2027
1 condition1 sponsor22 locations
NCT06047093
Fine Needle Aspiration (FNA) Evaluation of the Intrahepatic HBV Reservoir and Its Immunological Characteristics in Chronically HBV-infected Patients
NARecruiting
100 participants
Started: Mar 8, 2024 · Completed: Mar 8, 2028
1 condition1 sponsor1 location
NCT06202742
Cognitive Behavioral Therapy for Insomnia in Type 2 Diabetes Mellitus
NARecruiting
40 participants
Started: Mar 8, 2024 · Completed: Jun 30, 2025
2 conditions1 sponsor1 location
NCT06329271
After Hip Fracture Nailing, Compare Early Weight Bearing as Tolerated (WBAT) Group With Weight Bearing Restriction(WBR)
NARecruiting
60 participants
Started: Mar 8, 2024 · Completed: Apr 29, 2025
1 condition1 sponsor1 location
NCT06048133
Study of Gemcitabine, Cisplatin, AB680 and AB122 During First Line Treatment of Advanced Biliary Tract Cancers (QUIC)
PHASE2Recruiting
33 participants
Started: Mar 8, 2024 · Completed: Jul 31, 2027
3 conditions4 sponsors4 locations
NCT06493201
Research Into Risk Factors for Hospitalization Following a Fall in Older Patients
N/ARecruiting
60 participants
Started: Mar 8, 2024 · Completed: Mar 8, 2025
1 condition1 sponsor1 location
NCT06205186
Four Pillars of Defense: A Whole Health Approach to the Military
NARecruiting
400 participants
Started: Mar 8, 2024 · Completed: Jan 15, 2027
1 condition1 sponsor1 location
NCT06240143
Intradermal Ipilimumab and Nivolumab in High Risk Stage II Melanoma
PHASE1/PHASE2Recruiting
96 participants
Started: Mar 8, 2024 · Completed: Mar 31, 2034
1 condition1 sponsor6 locations
NCT06312124
A Study of Opportunistic Salpingectomy to Prevent Ovarian Cancer
NARecruiting
266 participants
Started: Mar 8, 2024 · Completed: Mar 8, 2028
1 condition1 sponsor10 locations
NCT06765213
Human Breast Milk's Role in Food Allergy Development
N/ARecruiting
20 participants
Started: Mar 8, 2024 · Completed: Dec 31, 2026
4 conditions2 sponsors1 location
NCT06412289
Comparison of the Diagnostic Accuracy: US-guided Percutaneous Lung Biopsies vs CT-guided in Peripheral Lung Lesions
NARecruiting
236 participants
Started: Mar 8, 2024 · Completed: Oct 31, 2026
1 condition1 sponsor2 locations
NCT06088771
Neoadjuvant Dupilumab and Cemiplimab in Patients With Early-stage Resectable NSCLC
PHASE1/PHASE2Recruiting
21 participants
Started: Mar 8, 2024 · Completed: Apr 22, 2027
1 condition1 sponsor1 location
NCT06063122
Development of a Therapeutic Device to Improve Speech Sound Differentiation in Preterm Infants
NARecruiting
203 participants
Started: Mar 8, 2024 · Completed: Feb 1, 2026
1 condition3 sponsors2 locations
NCT06239636
First-in-human Safety Study of Hypoimmune Pancreatic Islet Transplantation in Adult Subjects With Type 1 Diabetes
EARLY_PHASE1Recruiting
2 participants
Started: Mar 8, 2024 · Completed: Jun 30, 2025
1 condition2 sponsors1 location
NCT06479460
Clinical Application of ctDNA Dynamic Monitoring in Neoadjuvant Therapy for HER2-positive Breast Cancer Patients
N/ARecruiting
50 participants
Started: Mar 8, 2024 · Completed: Mar 31, 2026
4 conditions1 sponsor1 location
NCT05028712
Development of a Multi-sensory Rehabilitation Program for People With Ultra Low Vision
NARecruiting
36 participants
Started: Mar 8, 2024 · Completed: Jul 31, 2026
4 conditions1 sponsor1 location
NCT06421116
Validation of a Preclinical Model Based on Patient-derived Organoids for the Study of the Gut-joint Axis in Spondyloarthritis
N/ARecruiting
60 participants
Started: Mar 7, 2024 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT06286358
Aortopathy Relationship to Imagery and Kinocardiography Features (ARTIK)
N/ARecruiting
180 participants
Started: Mar 7, 2024 · Completed: Sep 30, 2025
2 conditions2 sponsors1 location
NCT06277050
Maintenance Therapy With Toripalimab and Capecitabine Versus Capecitabine Alone in High-risk Nasopharyngeal Carcinoma
PHASE3Recruiting
264 participants
Started: Mar 7, 2024 · Completed: Feb 20, 2030
3 conditions1 sponsor3 locations
NCT06204016
Estradiol and Stress Reactivity in Women
N/ARecruiting
74 participants
Started: Mar 7, 2024 · Completed: Dec 31, 2025
2 conditions4 sponsors1 location
NCT06791941
Study of the Contribution of Mutant p53/YAP Proteins to Therapy Resistance in Recurrent Head and Neck Cancer
N/ARecruiting
18 participants
Started: Mar 7, 2024 · Completed: Mar 7, 2029
1 condition1 sponsor1 location
NCT05632562
Multiparametic Metabolic and Hypoxic PET/MRI for Disease Assessment in High Grade Glioma
EARLY_PHASE1Recruiting
20 participants
Started: Mar 7, 2024 · Completed: Feb 1, 2026
1 condition1 sponsor2 locations
NCT06324149
Age-related Conditions in the Context of Multimorbidity and Frailty: Relative Weight of Frailty in Determining the Course and Outcomes of Different Chronic Diseases and Viceversa
N/ARecruiting
500 participants
Started: Mar 7, 2024 · Completed: Apr 30, 2026
2 conditions1 sponsor1 location
NCT06286059
Efficacy of Phentolamine in Prevention of Contrast-Associated Acute Kidney Injury After Complex PCI
PHASE2/PHASE3Recruiting
60 participants
Started: Mar 7, 2024 · Completed: Jan 31, 2025
4 conditions1 sponsor1 location
NCT05745350
First Line Pembrolizumab, Plinabulin Plus Etoposide and Platinum (EP) for ES-SCLC
PHASE2Recruiting
45 participants
Started: Mar 7, 2024 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT06829914
Shockwave™ vs Surgical Endarterectomy for Calcified Severe Common Femoral Artery Stenosis: Comparison of Efficacy, Safety and Long-Term Outcomes
NARecruiting
60 participants
Started: Mar 7, 2024 · Completed: Mar 30, 2026
2 conditions1 sponsor1 location
NCT06557044
The Analgesic Efficacy of Pericapsular Nerve Group (PENG) Block in Patients Undergoing Primary Total Hip Arthoplasty:
NARecruiting
110 participants
Started: Mar 7, 2024 · Completed: Mar 31, 2025
3 conditions2 sponsors1 location